The Effects of Prematurity on Visual Development
The Effects of Prematurity on Visual Development
批准号:
7483009
负责人:
WILLIAM V GOOD
金额:
$34.97万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-15 至 2010-08-31
关键词:
AffectAgeAge-MonthsBilateralBiological AssayBlindnessCerebrumChildComplicationConditionContrast SensitivityDetectionDevelopmentDiffusion Magnetic Resonance ImagingEarly DiagnosisEffectiveness of InterventionsElectroencephalographyFutureGestational AgeGoalsHeadImageImpairmentInfantInjuryInterventionLeadLifeLocationMagnetic Resonance ImagingMeasuresMedicalMethodsMonitorMorbidity - disease rateNeonatologyNervous System TraumaNewborn InfantNormal RangeNurseriesPathologyPatternPremature InfantPremature aging syndromePrematurity of fetusPreventionRangeRateRehabilitation therapyRoleScanningStructureStructure-Activity RelationshipSurvival RateTestingTimeUltrasonographyVisionVisual evoked cortical potentialVisual impairmentVisual system structureWeekexpectationimprovedinsightintraventricular hemorrhagenervous system disorderpostnatalpreventvision developmentvisual stimuluswhite matter damage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nearly one in every eight children is born prematurely in the US, yet very little is known about visual development or patterns of vision damage in this large group of children. The leading cause of bilateral low vision in children in the US is cerebral visual impairment (CVI), usually caused by neurological injury in premature infants. This condition will be potentially preventable or amenable to treatment in the near future as new therapies emerge for the prevention and treatment of neurological disease that result from extreme prematurity. Clearly, better methods to test and assay vision are needed. Otherwise, there will be no accurate way to judge the effects of medical or rehabilitative intervention. In this study, we will measure visual development in healthy, premature infants less than 32 weeks gestational age, and compare this to full term infants. Sweep VEP grating acuity, vernier acuity, and contrast sensitivity measures will be obtained at 6, 9, and 12 months chronological age in the premature group, and at 3, 6, 9, and 12 months chronological age in the fullterm group. In a second aim, we will measure these same three visual functions at 6, 9, and 12 months in infants who suffer an intraventricular hemorrhage (IVH) as a complication of prematurity. Results from this study will provide important information about visual development in normal premature infants, and the manner in which such visual development is perturbed by extreme prematurity and neurological damage (IVH). In a third aim, we will evaluate the role of diffusion tensor imaging (DTI) in identifying infants with vision abnormalities. DTI is performed early in the infant's life, at a time when intervention is most likely to prevent or treat neurological damage. By performing a structure-function analysis, comparing the spectrum of acuity changes in children with the spectrum of changes on their scans, we expect to be able to identify those children who have suffered damage to their visual system. This will allow early detection of vision abnormalities and pave the way for early medical and rehabilitation efforts. A comparison of head ultrasound and DTI findings will demonstrate whether DTI should replace ultrasound for the diagnosis of neurological injury in the newborn nursery.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Technology and retinopathy of prematurity diagnosis: the new frontier.
早产儿诊断技术和视网膜病变:新领域。
DOI:
10.1001/archopht.125.11.1562
发表时间:
2007
期刊:
Archives of ophthalmology (Chicago, Ill. : 1960)
影响因子:
--
作者:
[Good,WilliamV]
通讯作者:
Good,WilliamV
Retinopathy of prematurity and the peripheral retina.
早产儿视网膜病变和周边视网膜。
DOI:
10.1016/j.jpeds.2008.07.002
发表时间:
2008
期刊:
The Journal of pediatrics
影响因子:
--
作者:
[Good,WilliamV]
通讯作者:
Good,WilliamV
DOI:
10.4076/1757-1626-2-8970
发表时间:
2009-08-25
期刊:
Cases journal
影响因子:
--
作者:
[London NJ, Carden SM, Good WV]
通讯作者:
Good WV
Standardization of retinopathy of prematurity clinical examinations in clinical trials: risks, benefits and alternatives.
临床试验中早产儿临床检查视网膜病变的标准化:风险、益处和替代方案。
DOI:
10.1111/j.1442-9071.2008.01673.x
发表时间:
2008
期刊:
Clinical & experimental ophthalmology
影响因子:
4
作者:
[Good,WilliamV]
通讯作者:
Good,WilliamV
Genomics and proteomics of retinopathy of prematurity: DNA-based prevention and treatment.
早产儿视网膜病变的基因组学和蛋白质组学:基于 DNA 的预防和治疗。
DOI:
10.1136/bjo.2007.124404
发表时间:
2007
期刊:
The British journal of ophthalmology
影响因子:
--
作者:
[Good,WV, Gendron,RL]
通讯作者:
Gendron,RL
Effects of Hyperbilirubinemia on Visuocortical Functioning in High-Risk Infants
-
批准号:10468725
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2019
-
负责人:WILLIAM V GOOD
-
依托单位:
Effects of Hyperbilirubinemia on Visuocortical Functioning in High-Risk Infants
-
批准号:10227981
-
项目类别:
-
资助金额:$65.12万
-
财政年份:2019
-
负责人:WILLIAM V GOOD
-
依托单位:
Effects of Hyperbilirubinemia on Visuocortical Functioning in High-Risk Infants
-
批准号:9803368
-
项目类别:
-
资助金额:$70.43万
-
财政年份:2019
-
负责人:WILLIAM V GOOD
-
依托单位:
Neonatal Jaundice and Vision Loss
-
批准号:7774426
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2010
-
负责人:WILLIAM V GOOD
-
依托单位:
Neonatal Jaundice and Vision Loss
-
批准号:8066603
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2010
-
负责人:WILLIAM V GOOD
-
依托单位:
The Effects of Prematurity on Visual Development
-
批准号:6968858
-
项目类别:
-
资助金额:$42.03万
-
财政年份:2005
-
负责人:WILLIAM V GOOD
-
依托单位:
The Effects of Prematurity on Visual Development
-
批准号:7122341
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2005
-
负责人:WILLIAM V GOOD
-
依托单位:
The Effects of Prematurity on Visual Development
-
批准号:7273560
-
项目类别:
-
资助金额:$42.39万
-
财政年份:2005
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:7277196
-
项目类别:
-
资助金额:$20.51万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:6179064
-
项目类别:
-
资助金额:$11.08万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:6943843
-
项目类别:
-
资助金额:$20.18万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:2823240
-
项目类别:
-
资助金额:$12.05万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:6384789
-
项目类别:
-
资助金额:$12.19万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:7122448
-
项目类别:
-
资助金额:$20.22万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:6658961
-
项目类别:
-
资助金额:$17.64万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:6524962
-
项目类别:
-
资助金额:$17.24万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:6941010
-
项目类别:
-
资助金额:$19.42万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
EARLY TMT RETINOPATHY OF PREMATURITY HEADQUARTER GRANT
-
批准号:7491019
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1999
-
负责人:WILLIAM V GOOD
-
依托单位:
PEDIATRIC LOW VISION
-
批准号:6384235
-
项目类别:
-
资助金额:$15.53万
-
财政年份:1998
-
负责人:WILLIAM V GOOD
-
依托单位:
PEDIATRIC LOW VISION
-
批准号:6178713
-
项目类别:
-
资助金额:$15.53万
-
财政年份:1998
-
负责人:WILLIAM V GOOD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: